LD-2 disclosure · 3rd Quarter - Termination
ISIS PHARMACEUTICALS
Coverage · No income or expenses were reported on this filing.
Client
- Description
- pharmaceutical research company
- Location
- California · United States of America
Registrant
- Description
- Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesPharmacy
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249.
LobbyistsSTEPHEN M RYAN · KAREN SEALANDER · mr DAVID DUANE RANSOM
Covered position (STEPHEN M RYAN): Organized Crime.
Covered position (mr DAVID DUANE RANSOM): Member).
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249.
LobbyistsSTEPHEN M RYAN · KAREN SEALANDER · mr DAVID DUANE RANSOM
Covered position (STEPHEN M RYAN): Deputy Counsel, President's Commission on
Covered position (mr DAVID DUANE RANSOM): Member)
TargetedSENATE · HOUSE OF REPRESENTATIVES